A multi-centric Phase II study of intraperitoneal docetaxel combined with S-1 for patients with peritoneal dissemination of gastric cancer
Phase 1
- Conditions
- primary gastric cancer with peritoneal dissemination
- Registration Number
- JPRN-UMIN000002736
- Lead Sponsor
- Society for the Study of Peritoneal Dissemination in Gastric Cancer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Severe medical condition 2. Malignant tumors of other organs 3. massive pleural effusion/ascites
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety (completion rate)
- Secondary Outcome Measures
Name Time Method